C-Lab Ltd
TASE:CLAB
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
834.3
1 718
|
Price Target |
|
We'll email you a reminder when the closing price reaches ILS.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
C-Lab Ltd
Accrued Liabilities
C-Lab Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
C
|
C-Lab Ltd
TASE:CLAB
|
Accrued Liabilities
â‚Ş615k
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
Nano Dimension Ltd
NASDAQ:NNDM
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
W
|
Wearable Devices Ltd
NASDAQ:WLDS
|
Accrued Liabilities
$1.1m
|
CAGR 3-Years
107%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C-Lab Ltd
Glance View
C-LAB Ltd. engages in the development, production, marketing, and sale of computer systems. The firm operates through the following segments: Embedded Computer Systems or Computers-on-Modules (CoM) and Mini PC. The CoM segment produces and installs miniature computers including hardware and software, developed by the Company to be embedded in its clients' products. The Mini PC segment produces and markets computers, developed by the Company to be used as terminals. Its product categories include: CoMs, Miniature fan-less PCs and Airtop Line. CoMs are single circuit boards, with the functionality of a complete computer, that serve as the building blocks and the computing power for a number of electronic products, including smart electronic devices.
See Also
What is C-Lab Ltd's Accrued Liabilities?
Accrued Liabilities
615k
ILS
Based on the financial report for Dec 31, 2023, C-Lab Ltd's Accrued Liabilities amounts to 615k ILS.
What is C-Lab Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
-29%
Over the last year, the Accrued Liabilities growth was -78%. The average annual Accrued Liabilities growth rates for C-Lab Ltd have been -42% over the past three years , -29% over the past five years .